- Business Wire•1 hour agoMSD Animal Health Demonstrates Commitment to Eliminate Rabies Worldwide with Donation of More Than Two Million Doses of Vaccine to Date
MSD Animal Health is proud to announce a landmark accomplishment in its fight against rabies with the donation of now more than two million doses of its NOBIVAC® rabies vaccine to organizations working to eliminate this completely preventable disease.
- Business Wire•2 hours agoTwo New Trials of Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer to be Presented During Presidential Session at ESMO 2016
Merck , known as MSD outside the United States and Canada, today announced that extensive data on KEYTRUDA® , the company’s anti-PD-1 therapy, have been accepted for presentation at the European Society for Medical Oncology 2016 Congress in Copenhagen, Denmark, Oct.
- Market Realist•yesterday
Mylan's commercial developments include the acquisition of Renaissance Acquisition Holdings' tropicals business and the acquisition of Meda Aktiebolag.
Merck & Co., Inc. (MRK.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
|Day's Range||95.65 - 95.65|
|52wk Range||71.00 - 95.65|
|1y Target Est||N/A|
|P/E Ratio (ttm)||52.47|
|Avg Vol (3m)||1,166|
|Dividend & Yield||N/A (N/A)|